Mel Ziman
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 44
- Cancer Cells and Metastasis 25
- Cancer Immunotherapy and Biomarkers 14
- Cutaneous Melanoma Detection and Management 12
-
- Genetic Neurodegenerative Diseases 22
- Co-authors
- Elin S. GrayPauline ZaenkerJudith A. BlakeMichael MillwardLeslie CalapreTravis CruickshankÁlvaro ReyesJennifer A. Thompson
- Journals
- Australasian Journal of Paramedicine (17 papers)Scientific Reports (6 papers)Cancers (6 papers)Oncotarget (6 papers)Cancer Letters (5 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mel Ziman
155 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 159
- Cancer Research 1.0k
- Oncology 1.3k
- Developmental Neuroscience 161
- Molecular Biology 2.1k
- Immunology 603
Countries citing papers authored by Mel Ziman
This map shows the geographic impact of Mel Ziman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Ziman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Ziman more than expected).
Fields of papers citing papers by Mel Ziman
This network shows the impact of papers produced by Mel Ziman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Ziman. The network helps show where Mel Ziman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mel Ziman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 10 | |
| 3 | 2021 | 9 | |
| 4 | 2020 | 16 | |
| 5 | 2020 | 11 | |
| 6 | 2020 | 48 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 12 | |
| 9 | 2019 | 18 | |
| 10 | 2018 | 20 | |
| 11 | 2018 | 82 | |
| 12 | DETECTION OF CHROMOSOMAL ABERRATIONS ASSOCIATED WITH PROGNOSIS OF UVEAL MELANOMA USING CIRCULATING TUMOUR CELLS | 2017 | 1 |
| 13 | 2014 | 14 | |
| 14 | 2013 | 44 | |
| 15 | In-class pharmacology conference: student communication and flexible delivery in an authentic learning experience | 2012 | 0 |
| 16 | 2012 | 49 | |
| 17 | 2009 | 28 | |
| 18 | 2009 | 7 | |
| 19 | 2007 | 4 | |
| 20 | 2004 | 20 |
About Mel Ziman
Mel Ziman is a scholar working on Oncology, Cellular and Molecular Neuroscience, Cancer Research, Molecular Biology and Neurology, having authored 159 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (25 papers), Genetic Neurodegenerative Diseases (22 papers), Cancer Genomics and Diagnostics (21 papers), Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cutaneous Melanoma Detection and Management (12 papers), Neurological disorders and treatments (10 papers) and Developmental Biology and Gene Regulation (10 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.3k citations), Developmental Neuroscience (161 citations), Molecular Biology (2.1k citations) and Immunology (603 citations). Mel Ziman has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Elin S. Gray, Pauline Zaenker, Judith A. Blake, Michael Millward, Leslie Calapre, Travis Cruickshank, Álvaro Reyes, Jennifer A. Thompson, Tarek Meniawy and Anna Reid. Their work appears in journals such as Australasian Journal of Paramedicine, Scientific Reports, Cancers, Oncotarget and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.